2026 ICD-10-CM Diagnosis Code E72.4Disorders of ornithine metabolism
ICD-10-CM Codes›E00–E89›E70-E88›E72
- Billable — Valid for Submission
- Chronic Condition
E72.4 is a billable ICD-10-CM diagnosis code for disorders of ornithine metabolism. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as disorder of ornithine metabolism. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Disorder of ornithine metabolism
- Hyperammonemia
- Hyperornithinemia
- Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
- Ornithine aminotransferase deficiency
- Ornithine carbamoyltransferase deficiency
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Hyperammonemia-Hyperornithinemia-Homocitrullinemia syndrome
- Ornithinemia (types I, II)
- Ornithine transcarbamylase deficiency
Type 1 Excludes
- hereditary choroidal dystrophy H31.2
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- ornithine transcarbamylase - E72.4
- Disorder (of) - See Also: Disease;
- metabolism NOS - E88.9
- amino-acid - E72.9
- ornithine - E72.4
- ornithine - E72.4
- ornithine metabolism - E72.4
- urea cycle metabolism - E72.20
- ornithine transcarbamylase deficiency - E72.4
- Disturbance (s) - See Also: Disease;
- metabolism - E88.9
- ornithine - E72.4
- ornithine - E72.4
- Hyperornithinemia - E72.4
- Ornithine metabolism disorder - E72.4
- Ornithinemia (Type I) (Type II) - E72.4
- Syndrome - See Also: Disease;
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Deficiency, deficient
- ornithine transcarbamylase
- Disorder(of)
- metabolism NOS
- amino-acid
- ornithine
- Disorder(of)
- metabolism NOS
- ornithine
- Disorder(of)
- ornithine metabolism
- Disorder(of)
- urea cycle metabolism
- ornithine transcarbamylase deficiency
- Disturbance(s)
- metabolism
- ornithine
- Hyperaminoaciduria
- ornithine
- Hyperornithinemia
- Ornithine metabolism disorder
- Ornithinemia(Type I) (Type II)
- Syndrome
- hyperammonemia-hyperornithinemia-homocitrullinemia
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Carbamoyl-Phosphate Synthase I Deficiency Disease
a urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. the disorder is caused by a reduction in the activity of hepatic mitochondrial carbamoyl-phosphate synthase (ammonia). (menkes, textbook of child neurology, 5th ed, pp50-1)Hyperammonemia
elevated level of ammonia in the blood. it is a sign of defective catabolism of amino acids or ammonia to urea.Hyperlysinemias
a group of inherited metabolic disorders which have in common elevations of serum lysine levels. enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the saccharopine dehydrogenases have been associated with hyperlysinemia. clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. (from menkes, textbook of child neurology, 5th ed, p56)Rett Syndrome
an inherited neurological developmental disorder that is associated with x-linked inheritance and may be lethal in utero to hemizygous males. the affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ataxia; seizures; autistic behavior; intermittent hyperventilation; and hyperammonemia appear. (from menkes, textbook of child neurology, 5th ed, p199)
Patient EducationClinical
Amino Acid Metabolism Disorders
Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Your digestive system breaks the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E72.4 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E72.4Overview
Is E72.4 (Other disorders of amino-acid metabolism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report disorders of ornithine metabolism on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E72.4?
Under the General Equivalence Mappings, disorders of ornithine metabolism converts to ICD-9-CM 270.6 (dis urea cycle metabol). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
